Arkolith/Insider Trading/CMMB/Form 4

Pfost Dale R

Chief Executive Officer, DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 15, 2022
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2022Buy(P)700$3.97$3K3K
Mar 14, 2022Buy(P)2K$3.98$7K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 25, 2021Grant(A)459K—$0459K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-001120) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML